COMIRNATY COVID-19 VACCINE (Pfizer Australia Pty Ltd)
Product name
COMIRNATY COVID-19 VACCINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
25 (255 working days)
Active ingredients
tozinameran
Registration type
EOI
Indication
COMIRNATY COVID-19 VACCINE (suspension for injection) is now also indicated for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 5 years of age and older.
Registration process
Provisional registration
Involves early access to vital and life-saving medicines through time-limited registration